Asfru n tɣellist tabaḍnit: Aseklu n temsesferḥin yettwazeggiren yella-d s wallaf n umaḍal

Yekkat deg tama meqqren n Tmurt n Leqbayel di Lezzayer, tamnaḍt n Tizi Wezzu d tamehla i yesɛan iṣeggen iɣezfan deg temseɣẓẓaḍt tabaḍnit, tussni tamẓlayt akked tɣellist n tgemṭ. Ula d akken asefrek anida i d-yezrin kanabis yellan yettemcabi mayen, ayen yettnadin imdanen akk s tɣellist s tarrayin tibaḍanin ayen i nettemcabi akk. OilWell Cannabis, nɛabbed azal n tlelli i tɣellist s temsesferḥin yella-d ɣef umaḍal akken ad nexdem tiriẓi i wakken ad nessen amek ara ten-nesqedcen s yiwet n tarrayt taɣersant.

Tutlayt tamatut i tɣellist yerwan seg yimɣan

Deg yakk imeṭṭi d yimeɣan, imezdaɣ teddun s yimɣan i wakken ad ffɣen seg temsujjya, ad d-selḥen, akked waddad ɣer wayen yernan. Seg tussni tamẓlayt timenzay n teqbaylit ɣer timsagniyin tura, asdukkel gar yimɣan akked tɣellist n umaḍal yessakan-d aggur n usfru. Ayen i ferḥen n uxeddim i wakken ad netwass yella-d mačči d ayen nefka i tɣellist kan, maca d ayen nebɣa ad nessken amek ara nessuffeɣ yis tussni tamẓlayt s yiswiyen iɛlayen, nesseɣti timaktiwin i yezgan deg tɣellist tabaḍnit s tɣara n tḥerrit akked tmenṣewt timeẓlayin.

Tarik-nneɣ ur yebḍu ara mayebda s tarrayin n uxeddim, maca s wayen yebɣan ad iɛawen yiwet n twacult i wakken ad teẓreg tamdint n tɣellist. Mi tennerna biḍan n unbaḍ n OilWell, Bentley, yebded ad yeḥbes, sɣur iḍebsi yessefk ad yemmeyyen, aselmed asertan ur yegmir ara. Ayen yebɣu ad yili amahil yekka-d s yiwet n tsuqert ur nettura ara: “Tettnadiḍ taskayt n wa ɣef wayen yettemcabin s DDK mačči d akka?”. Ayagi yeffeɣ-d deg usali n wazal meqqren i tɣellist tabaḍnit, n uxeddim i wakken ad nefhem amek ara nesseqdac tasmektit-nni, imiren tuɣal d yiwen n yimenɣi i wakken ad tili d yerwan iɣellisen nniḍen. Ayen yebɣu ad yesɛu Bentley 10 n yiseggasen yernan yekfa-d akken ad yili d amezwaru n uɣanib i trebbaɛ n OilWell.

Timensiwin tigejdanin n temsesferḥin yella-d s iɣaniben n kanabis

I wakken ad nefhem amak i tɣellist tabaḍaninǦ s temsesferḥin i deg yella-d kanabisǦ tebɣa ad nessukseṛ timenna n tekluyt teɣersant (endocannabinoid system) – d yiwen n uḍebsi anida i yexdimen imudren n tedbelt, gar-asen imdanen d lǧwayeṛ. Tettwaf deg tallit n 1990 sɣur yinefluyen deg usali amek THC teṭṭafar agerzum, tekluyt teɣersant tettwakkes d yiwen n umḍan n yimenyafen i d-yezgan deg yakk lǧwayeṛ, gar-asen:

• Iɣaniben CB₁ (ttwassnen deg uqerru akked tmennaḍt tamatut n tedbelt)
• Iɣaniben CB₂ (ttwafen deg yimɣan akked tmennaḍt tugar n tedbelt)
• Iɣaniben yettwaxedmen sɣur igenni n umaḍal (anandamide d 2-AG)
• Iniɣmisen yettwagzam sɣur tɣellist n umaḍal

Uḍebsi-agi ur yekka ara i wakken ad yili d ayen i nettnadi i kanabis – dɣa, iɣaniben n kanabis ttemcabin s cwiṭ s uḍebsi anida i yexdimen timerna n uɣanib am tmenɣiwt, tɣellist n umaḍal, tɣellist n tedbelt, aselkem n wudem, tɣellist n wakal akked tɣellist n wakken ad yeɛreḍ seg ugur. Ma yella uḍebsi-agi yeffeɣ-d seg tɣellist, i wakken ad yili d ayen i nettnadi i wakken ad yili d ayen i nettnadi i wakken ad yili d ayen i nettnadi i wakken ad yili d ayen i nettnadi i wakken ad yili d ayen i nettnadi i wakken ad yili d ayen i nettnadi. Tirak n OilWell tettwaxdem s wudem i yettunefken i wakken ad yili d ayen i yessefk ad yili iɣellisen nniḍen s wudem n tɣara i wakken ad mmesten tɣellist n umaḍal.

Asfru n DDK Rick Simpson n uzwel

Gar tinefluyen-nneɣ i d-yezgan deg uzwel, n DDK Rick Simpson Oil – d yiwen n usfeṛ yesɛan azal meqqren i wakken ad yili d ayen i yeɛawen akken ad yili d ayen i yettwaḥsaben s tɣara n tmenṣewt, i wakken ad yili d ayen i yessefk ad yili iɣellisen nniḍen s wudem n tɣara i wakken ad mmesten tɣellist n umaḍal. Ula d akken tirak n DDK Rick Simpson i d-yezgan deg yiwen n usfeṛ ur nettwass ara s wudem n tɣara i wakken ad yili d ayen i yessefk ad yili iɣellisen nniḍen s wudem n tɣara i wakken ad mmesten tɣellist n umaḍal.

Asfeṛ n DDK Rick Simpson (16,590mg n yiberkanen deg yiwet n tecṛuqt 30mL):

Tarak-nneɣ d ayen i d-yezgan deg wazal n yiseggasen n usfeṛ, nesdukkel 6 n yiberkanen s tarrayin i yettwassnen sɣur tiriẓi d usseqdec deg tdles:

• DDK (4,500mg): D aɣanib amezwaru i yesɛan tiriẓi i wakken ad yili d ayen i yettwasnen i wakken ad yessefk ad yili iɣellisen nniḍen. Tarrayt tasnawant: C₂₁H₃₀O₂.
• Delta-8 THC (6,000mg): Iṭṭaf tarraytin temcabin i THC s cwiṭ akken yella-d i wakken ad yili d ayen i yessefk ad yili iɣellisen nniḍen. Tettwassn sɣur Journal of Cannabis Research deg useggas 2022 (N=521) anida 74% ur sɛin ara agur, 83% ur sɛin ara tagnit.
• CBG (3,000mg): D “aɣanib ameqqran” i d-yeffɣen akk iberkanen-nniḍen, yettwakkes d ayen i yessefk ad yili iɣellisen nniḍen deg Washington State University deg useggas 2024 (N=34) i d-yeskanen amek ara yessefk ad yili iɣellisen nniḍen s wudem n tɣara iwakken ad yesɛu agur ur nettwass ara.
• THCa (1,500mg): Deg tarrayt tazrawt, aɣanib-agi ur yesɛi ara tɣellist n umaḍal yettwakkes d ayen i yessefk ad yili iɣellisen nniḍen s wudem n tɣara i wakken ad yili d ayen i yessefk ad yili iɣellisen nniḍen (NIH 2023) akked PPARγ (NIH 2024). S tedbelt n wudem (asemẓi), ad yili d ayen i yessefk ad yili iɣellisen nniḍen i wakken ad yili d ayen i yettwaḥsaben s wudem n tɣara.
• CBN (750mg): D ayen i yessefk ad yili iɣellisen nniḍen i wakken ad yili d ayen i yessefk ad yili iɣellisen nniḍen, yettwassn sɣur University of Sydney deg useggas 2024 i d-yeskanen amek ara yessefk ad yili iɣellisen nniḍen deg NREM d REM am tarrayin n userwes.
• BBC (750mg): Iɛawen deg usnulfu n yinefluyen n tedbelt akked tarraytin yellan d ayen i yessefk ad yili iɣellisen nniḍen.
• Terpenes (5%): Ad mmestnen tarrayt n w

ENGLISH

Discovering Natural Wellness: Exploring Complementary Plant Therapies with Global Perspective

Nestled within the beautiful Kabylia region of Algeria, Tizi Ouzou Province represents a culture with deep-rooted traditions in natural healing, botanical knowledge, and community wellness. While the specific regulatory landscape surrounding cannabis varies globally, the universal human quest for wellbeing through natural means connects us all. At OilWell Cannabis, we honor the rich heritage of plant-based therapies found in cultures worldwide while advancing the scientific understanding of cannabinoids and functional mushrooms through rigorous research and pharmaceutical-grade standards. Our journey from Houston, Texas, to serving a global community is built on a foundation of education, transparency, and respect for diverse approaches to health.

The Universal Language of Plant-Based Wellness

Across continents and cultures, humanity has always turned to nature for relief, healing, and spiritual connection. From the traditional herbal knowledge preserved in the Kabyle culture to modern scientific laboratories, the relationship between plants and human wellness represents a continuum of discovery. What makes our work at OilWell Cannabis unique isn’t just our products—it’s our commitment to bridging traditional plant wisdom with cutting-edge science, creating formulations that honor nature’s complexity while meeting pharmaceutical standards of purity and consistency.

Our story begins not with business ambitions, but with a personal crisis that taught us the true power of plant-based therapies. When Bentley, our founder’s pitbull, faced paralysis and a veterinary recommendation for euthanasia, conventional medicine had reached its limits. The discovery that changed everything came from an unexpected question: “You’ve moved how many tons of weed and you’ve never heard of CBD?” This moment of revelation launched a decade of intensive research, formulation development, and ultimately, the miraculous recovery that gave Bentley ten additional years of life. That journey from desperation to discovery forms the ethical foundation of everything we create.

The Scientific Foundation of Cannabinoid Therapy

To understand why plant-based therapies show such remarkable potential, we must explore the endocannabinoid system (ECS)—a biological network present in all vertebrates, including humans and animals. Discovered in the 1990s through research on how THC affects the brain, the ECS represents an entire signaling system comprising CB₁ receptors (concentrated in the brain and central nervous system), CB₂ receptors (found throughout immune tissues and peripheral nervous system), endogenous cannabinoids produced by our bodies (anandamide and 2-AG), and metabolic enzymes that regulate these compounds.

This system didn’t evolve in response to cannabis—rather, cannabis compounds happen to interact powerfully with a biological system that regulates fundamental processes including pain perception, mood balance, immune response, sleep cycles, appetite, and stress adaptation. When this system falls out of balance, whether through illness, injury, or chronic stress, plant-derived cannabinoids may offer supportive modulation. Our formulations at OilWell are designed with this sophisticated biological interplay in mind, creating full-spectrum products that work with the body’s natural systems rather than overwhelming them.

Introducing the World’s First Legal Pharmaceutical-Grade RSO

Among our most significant innovations is our THCa Rick Simpson Oil—a revolutionary formulation that brings the traditional benefits of full-spectrum cannabis oil into a legal, standardized, pharmaceutical-grade format. Unlike traditional RSO that exists in legal gray areas, our formulation complies with the 2018 U.S. Farm Bill while delivering therapeutic concentrations previously only available through underground or medical-program channels.

The Complete RSO Formula (16,590mg Total Cannabinoids per 30mL Bottle):

Our proprietary formula represents years of refinement, combining six distinct cannabinoids in precise ratios validated by both clinical research and real-world application:

• CBD (4,500mg): The foundational cannabinoid with extensive research supporting its calming and anti-inflammatory properties. Molecular formula: C₂₁H₃₀O₂.
• Delta-8 THC (6,000mg): Offering similar benefits to traditional THC with significantly reduced anxiety and paranoia, as demonstrated in the Journal of Cannabis Research 2022 study (N=521) where 74% reported no anxiety and 83% no paranoia.
• CBG (3,000mg): The “mother cannabinoid” from which all others derive, showing remarkable neuroprotective properties in Washington State University’s 2024 research (N=34) demonstrating significant anxiety reduction at just 20mg doses.
• THCa (1,500mg): In its raw form, this non-psychoactive compound shows potent anti-inflammatory activity via COX-2 inhibition (NIH 2023) and PPARγ receptor agonism (NIH 2024). Through decarboxylation (heating), it converts to THC, allowing patients to control their therapeutic experience.
• CBN (750mg): Nature’s sleep aid, validated by University of Sydney 2024 research showing objective increases in both NREM and REM sleep comparable to pharmaceutical sleep aids.
• CBC (750mg): Supporting neurogenesis and working through unique pathways including anandamide reuptake inhibition.
• Live Terpenes (5%): Preserving the complete aromatic profile that contributes to the entourage effect—the synergistic interaction between all cannabis compounds.

Dual-Pathway Patient Empowerment

What makes our THCa RSO particularly innovative is the dual-pathway technology. When taken sublingually without heating, patients receive the therapeutic benefits of THCa—anti-inflammatory, neuroprotective effects without psychoactivity. When decarboxylated through heating, the same formula converts to deliver full-spectrum effects. This puts control directly in patients’ hands, allowing them to tailor their experience to their needs, comfort level, and therapeutic goals.

Pharmaceutical Cost Comparison

The economic accessibility of plant-based therapies becomes strikingly clear when comparing our formulations to conventional pharmaceuticals:

• Epidiolex (FDA-approved CBD): $30,000-$50,000 annually versus our RSO at $519.96 annually (four bottles for maintenance).
• Marinol (synthetic THC): $12,000-$24,000 annually.
• Sativex (THC:CBD combination): $7,200-$9,600 annually.
• Prescription Opioids: $4,800-$9,600 annually plus addiction and overdose risks.

Our commitment to affordability comes directly from Rick Simpson’s original principle that medicine should be accessible. While Simpson gave his oil away freely (helping over 5,000 people), we’ve created a sustainable business model that allows us to scale his vision globally while maintaining pharmaceutical-grade quality control.

Premium THCa Flower: Artisanal Cultivation Meets Scientific Precision

For those seeking the traditional cannabis experience with modern quality assurance, our THCa flower collection represents the pinnacle of artisanal cultivation enhanced by scientific understanding. Each strain is selected not just for potency, but for its unique therapeutic profile based on cannabinoid ratios and terpene expressions.

Elite Tier Selections (35%+ THCa)

Pink Pineapple THCa Flower (35-38% THCa):
A balanced hybrid (50% Sativa/50% Indica) born from Pink Kush and Pineapple Express genetics, featuring a terpene profile rich in myrcene (0.6-0.9%), limonene (0.4-0.7%), and pinene (0.3-0.5%). This strain exemplifies our focus on cognitive support, offering clarity and focus without anxiety—ideal for creative pursuits or managing executive function challenges.

Cherry Gushers THCa Flower (35%+ THCa):
An indica-dominant hybrid (70% Indica/30% Sativa) from Açaí and Black Cherry Funk lineage, expressing high concentrations of limonene (0.5-0.9%) and β-caryophyllene (0.3-0.7%). The significant β-caryophyllene content is particularly noteworthy as this terpene directly activates CB₂ receptors, offering anti-inflammatory benefits without psychoactivity. This makes Cherry Gushers particularly valuable for autoimmune conditions, inflammatory disorders, and pain with an inflammatory component.

Premium Tier Excellence (28-34% THCa)

Sunset Fritter THCa Flower (33% THCa):
An award-winning hybrid (Apple Fritter × Sunset Sherbet) that has earned eight Cannabis Cup championships. The triple pain pathway terpene science—featuring limonene (0.44%), β-caryophyllene (0.20%), and myrcene (0.19%)—creates comprehensive pain relief through multiple mechanisms simultaneously. This represents a significant advance over single-pathway pharmaceuticals, addressing pain at the inflammatory, neurological, and muscular levels concurrently.

Lemon Pound Cake THCa Flower (28-32% THCa):
A sativa-dominant hybrid (70% Sativa/30% Indica) whose therapeutic profile has been validated by Johns Hopkins University 2024 research on limonene. At concentrations of 0.8-1.4%, the limonene in this strain delivers what researchers identified as the clinical dose that reduced THC-induced anxiety by 54.8% in their double-blind, placebo-controlled study (N=20). This represents one of the first clinically validated examples of the entourage effect—where specific terpenes significantly modulate cannabinoid effects.

Biscotti THCa Flower (28-33% THCa):
An indica-dominant hybrid (Gelato #25 × South Florida OG) featuring a neurological terpene matrix emphasizing linalool, pinene, and humulene. Beyond immediate effects, this profile supports long-term neurological wellness, with applications in age-related cognitive support, neuropathic pain management, and overall brain health maintenance.

The Terpene Revolution: Beyond Cannabinoids

Modern cannabis science has revealed that therapeutic effects depend on far more than just THC and CBD percentages. The aromatic compounds called terpenes—the same compounds that give plants their distinctive scents—play crucial roles in modulating effects and contributing therapeutic benefits:

• β-Caryophyllene: The only terpene known to directly activate CB₂ receptors, offering anti-inflammatory benefits without psychoactivity. University of Arizona 2024 research (NIH Award R01AT011517) studied its pain-relevant properties in mouse models.
• Limonene: Validated by Johns Hopkins 2024 research to reduce THC-induced anxiety by 54.8% when administered at clinical doses alongside THC.
• Myrcene: Enhances THC’s permeability through the blood-brain barrier while contributing sedative and muscle-relaxant properties.
• Linalool: Interacts with GABA receptors similar to some anti-anxiety medications, promoting relaxation without pharmaceutical side effects.

Our cultivation practices preserve these delicate terpenes through slow-cure processes (minimum 60 days at 60°F and 60% humidity) and nitrogen-sealed packaging that maintains freshness during global shipping.

Functional Mushroom Synergy: The Next Frontier in Natural Wellness

Recognizing that traditional healing systems worldwide have utilized mushrooms alongside botanical medicines, we’ve pioneered formulations that combine cannabis with functional mushrooms for enhanced benefits. This represents not just product innovation, but a philosophical commitment to holistic wellness that respects multiple traditional healing pathways.

Seshnz Functional Mushroom Formulas

Our Seshnz line represents years of research into mushroom-cannabis synergy, creating targeted formulations for different times of day and wellness goals:

Seshnz Day Sesh Gummies:
Formulated for morning and daytime use, this blend emphasizes Lion’s Mane (40%) for cognitive enhancement and neurogenesis support, Cordyceps (30%) for natural energy and respiratory support, Chaga (20%) for antioxidant protection, and Reishi (10%) for adaptogenic stress support. The combination provides sustained energy without stimulants, mental clarity without anxiety, and immune support without over-activation.

Seshnz Night Sesh Gummies:
Designed for evening restoration, this formula features Reishi (50%) for deep relaxation and sleep support, Chaga (25%) for overnight antioxidant protection, Lion’s Mane (15%) for cognitive restoration during sleep, and Cordyceps (10%) for cellular recovery. This represents a comprehensive approach to sleep that addresses not just sleep induction, but sleep quality and next-day restoration.

Scientific Validation of Synergy:
Emerging research suggests multiple mechanisms for mushroom-cannabis synergy:

• Mushroom beta-glucans may enhance cannabinoid absorption through improved gut health
• Shared terpene profiles create complementary therapeutic effects
• Adaptogenic properties of mushrooms may enhance cannabis’s stress-relief benefits
• Neuroprotective compounds in both categories work through complementary pathways

Pharmaceutical-Grade Manufacturing: Our Quality Commitment

What separates OilWell Cannabis from both underground producers and many legal-market competitors is our uncompromising commitment to pharmaceutical-grade standards. While based in Houston, Texas, our quality protocols meet or exceed international standards suitable for global distribution:

Complete Testing Protocol

Every batch undergoes 14-point verification including:

• HPLC/UHPLC potency testing (±2% accuracy)
• ICP-MS heavy metals screening (arsenic, cadmium, lead, mercury below FDA limits)
• LC-MS/MS and GC-MS/MS pesticide screening (400+ compounds)
• Headspace GC residual solvent analysis (FDA Class 3 limits: <5,000ppm)
• Comprehensive microbial pathogen screening
• GC-MS terpene profiling for authenticity verification
• 24-month stability testing with accelerated aging studies

Cultivation Excellence

Our indoor cultivation facilities utilize living soil methodologies with mycorrhizal networks, full-spectrum LED lighting optimized for cannabinoid and terpene production, and climate control systems maintaining ideal conditions (68-75°F day/60-68°F night, 45-55% humidity, 1200-1500ppm CO₂). Harvest timing follows trichome analysis (70-80% cloudy, 20-30% amber) rather than arbitrary schedules.

Global Accessibility Through Responsible Shipping

While we offer same-day delivery within 60 miles of our Houston headquarters at 810 Richmond Ave, our global shipping network ensures responsible access worldwide. All packages feature discreet, professional packaging with appropriate documentation for international customs, maintaining product integrity through climate-controlled shipping when necessary.

Our Media-Recognized Authority

Our commitment to education and transparency has earned recognition from mainstream media, including eight separate features on ABC News. These segments haven’t been superficial celebrity endorsements, but substantive journalism about cannabis science, policy, and therapeutic applications:

• September 16, 2019: Our anti-“snake oil” stance during the CBD boom established us as quality advocates in an unregulated market.
• May 24, 2021: Our candid discussion about Delta-8 THC effects—”I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high”—represented honest consumer education when others offered evasion.
• August 20, 2021: Our $35,000 COVID-19 vaccine incentive program (1,000 special edition caviar pre-rolls) demonstrated community commitment over profit.
• October 19, 2021: Our immediate compliance when Texas reclassified Delta-8 showed regulatory leadership, protecting customers while warning the industry about unintended legal consequences.
• April 20, 2023: Our pragmatic analysis of Texas cannabis law evolution—”Right now is actually a pretty—like Renaissance—pretty important time that should be enjoyed now”—balanced advocacy with realistic market assessment.

These media relationships reflect our foundational philosophy: cannabis deserves serious discussion as both a therapeutic agent and a complex social policy issue.

B2B and Wholesale Partnerships: Building Global Quality Standards

For businesses worldwide interested in premium cannabinoid products, we offer comprehensive wholesale partnerships through multiple tiers (Diamond: >$1M annual volume, Platinum: >$500K, Gold: >$250K, Silver: >$100K). Our private label services provide:

• Custom formulations based on specific therapeutic targets
• Complete branding and packaging design support
• Regulatory compliance guidance for multiple jurisdictions
• Pharmaceutical-grade manufacturing with batch-specific certificates of analysis
• Market research and consumer insights for product development

Whether you’re a wellness center in Europe, a healthcare provider in Australia, or a retailer in Asia, our partnership programs ensure you receive the same quality and expertise that defines our direct consumer products.

Educational Commitment: Beyond Products to Understanding

True to our origins in Bentley’s rescue—which began with desperate research—we prioritize education alongside product excellence. Our resources include:

• Comprehensive cannabinoid and terpene science explanations
• Dosing guidelines based on weight, tolerance, and desired effects
• Drug interaction information (particularly CYP450 enzyme considerations)
• Patient stories and case studies (with appropriate privacy protections)
• Latest research summaries in accessible language
• Cultural and historical context about traditional plant medicine use worldwide

This educational commitment reflects our belief that informed consumers make better decisions about their wellness, whether they’re in Houston, Tizi Ouzou Province, or anywhere between.

Respecting Global Diversity in Wellness Approaches

As we consider the rich cultural traditions of regions like Tizi Ouzou Province, we recognize that wellness practices evolve within specific cultural, historical, and environmental contexts. Our approach isn’t to replace traditional knowledge but to offer complementary options that meet modern scientific standards while respecting traditional wisdom about plant-based healing.

The global interest in natural wellness represents a shared human impulse—to find balance, relief, and vitality through nature’s pharmacy. Whether through the aromatic herbs of Kabylia, the mushroom traditions of various indigenous cultures, or the cannabinoid research of modern laboratories, we’re all participating in the same fundamental exploration of how plants and fungi can support human health.

How to Explore Our Offerings Responsibly

For those interested in learning more about our research, products, or educational resources, we invite you to visit our website or contact our educational team. We recommend:

1. Beginning with our educational materials to understand cannabinoid science
2. Consulting with healthcare providers about potential interactions with existing treatments
3. Starting with low doses and gradual titration, following the “start low, go slow” principle
4. Considering your personal wellness goals and how different formulations might support them
5. Understanding local regulations and compliance requirements in your jurisdiction

Our customer service team includes multilingual staff trained in both product knowledge and compassionate communication, ensuring that questions receive thoughtful, accurate responses regardless of where they originate.

A Final Reflection on Natural Wellness Across Cultures

The journey from Bentley’s paralysis to global wellness education has taught us that hope often emerges where conventional approaches reach their limits. What began as one dog’s miraculous recovery has evolved into a comprehensive approach to plant-based wellness that respects scientific rigor, traditional knowledge, and individual autonomy.

Whether in the mountains of Kabylia or the urban centers where research laboratories advance our understanding, the fundamental human desire for wellness through nature creates connections across distance and difference. At OilWell Cannabis, we’re honored to contribute to this global conversation, offering products and education that bridge traditional plant wisdom with modern scientific validation.

As we continue our work from Houston while serving a global community, we carry forward the lessons from Bentley’s decade of extra life: that compassion should drive innovation, that quality matters more than quantity, and that sometimes the most profound healing comes from respecting nature’s complexity while applying human curiosity and care.

For those on their own wellness journeys—wherever they may be—we offer both specific products and broader perspectives, always with the humility that comes from knowing how much remains to be discovered about the intricate relationships between plants, fungi, and human wellbeing.

OilWell Cannabis
810 Richmond Ave, Houston, TX 77006, USA
Phone: (832) 416-2816 | Email: [email protected]
Website: https://oilwellcbd.com/ | Instagram: @oilwellcbd

Serving a global community with pharmaceutical-grade cannabis and functional mushroom products, educational resources, and compassionate support since 2015.